Partnership

CNRS :

Partnership with Dr. Sabatier:
IFR Jean Roche FR2738
Ingénierie des Peptides et Modélisation Moléculaire

Partnership with Dr Pepe
Groupe de Chimie Organique et Matériaux Moléculaires

INSERM :

Partnership with Dr. Lavillette :

U412 deposited a patent for the development of their system of the VHC pseudo-particles production. We plan to acquire a user licence of this technology in order to implement this technology in the company.

Assistance publique :
Partnership with Pr. Lacarelle :

The studies of pharmacokinetic and bioavailability not GMP are planned to be realized in partnership with Pr Bruno Lacarelle ( CHU Marseille , laboratoire de pharmaco-cinétique ).

STRATEGIC ALLIANCE

Gilead :

A master pharma company agreement signed with Gilead in the field of molecular mechanisms on HIV resistance with the Tenofovir (2004)

Cellpep :

A corporate agreement was signed with Cellpep in the developement of a specific program to Genmol software. This software will be specifically developed to predict the structure of proteins complex (March 2004)